Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
clindamycin (cleocin) (2 trials)
erythromycin (ilosone) (2 trials)
ethanol (1 trial)
amenamevir (8 trials)
pefcalcitol (9 trials)
valaciclovir (Valtrex) (1 trial)
anti-staphylococcus bacteriophage therapy (1 trial)
calcipotriene (dovonex) (1 trial)
m516102 (1 trial)
nemolizumab (1 trial)
bupropion (wellbutrin) (1 trial)
cyclosporine (sandimmune) (1 trial)
midazolam (versed) (1 trial)
montelukast (singulair) (1 trial)
ritonavir (Norvir) (1 trial)
sodium chloride (2 trials)
sodium monododecyl sulfate (2 trials)
clobetasol (dermovate) (1 trial)
lipopolysaccharide (1 trial)
prednisolone (hydeltra) (1 trial)
Acne Vulgaris (Phase 4)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Eczema (Phase 2)
Herpes Simplex (Phase 3)
Herpes Zoster (Phase 3)
Pruritus (Phase 2)
Psoriasis (Phase 3)
Trials (22 total)
Trial APIs (20 total)